Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to curb opioid overprescribing in primary care

NCT ID NCT03889418

Disease control Sponsor: Ochsner Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two ways to help primary care doctors prescribe opioids more safely for patients with chronic pain, depression, or anxiety. One approach used an electronic tool that reminded doctors about risk checks and guidelines. The other added a team of a pharmacist, a social worker, and a community health worker to provide extra support. The goal was to see which method better reduced high-dose opioid prescriptions. The trial involved 490 adults from multiple clinics in Louisiana.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electronic medical record clinical decision support tool and collaborative care (clinical pharmacist, social worker, community health worker)
What this could lead to
If successful, this approach could help primary care clinics reduce risky high-dose opioid prescribing and improve care for patients with chronic pain and mental health conditions.
What could go wrong
This is a completed implementation study, not a drug trial, so results may not apply to all clinics. The intervention relies on provider behavior change, which can be hard to sustain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

490 people

The number who actually took part.

Started

Apr 2019

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 and older 2. Have a primary care provider at any of the study clinics 3. Receiving chronic opioid prescriptions (3 of the prior 4 months) for chronic non-cancer pain 4. Have a diagnosis of depression or anxiety Exclusion Criteria: 1. Age less than 18 years 2. Active cancer or undergoing cancer treatment 3. Chronic cancer-related pain 4. Having a terminal illness 5. Receiving hospice care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Chronic Pain chronic pain syndrome Depression depressive disorder opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Chronic pain Depression Opioid use

Contacts and locations

Locations

  • Ochsner Health System - Research Dept

    New Orleans, Louisiana, 70121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.